TissGeneSummary for POM121L2 |
Gene summary |
Basic gene information | Gene symbol | POM121L2 |
Gene name | POM121 transmembrane nucleoporin-like 2 | |
Synonyms | POM121-L|POM121L | |
Cytomap | UCSC genome browser: 6p22.1 | |
Type of gene | protein-coding | |
RefGenes | NM_033482.3, | |
Description | OM121 membrane glycoprotein (rat homolog)-like 2POM121 membrane glycoprotein (rat homolog)-like 2POM121 membrane glycoprotein-like 2POM121-like protein 2 | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000158553 | ||
Vega : OTTHUMG00000014475 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_POM121L2 | |
BioGPS: 94026 | ||
Pathway | NCI Pathway Interaction Database: POM121L2 | |
KEGG: POM121L2 | ||
REACTOME: POM121L2 | ||
Pathway Commons: POM121L2 | ||
Context | iHOP: POM121L2 | |
ligand binding site mutation search in PubMed: POM121L2 | ||
UCL Cancer Institute: POM121L2 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of POM121L2 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for POM121L2 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
BLCA | -0.382163222 | -1.518305327 | 1.136142105 | 9.00E-04 | 0.00647767 |
Top |
TissGene-miRNA for POM121L2 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for POM121L2 |
TissGeneSNV for POM121L2 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.T626N | LIHC | 1 |
p.I745N | DLBC | 1 |
p.S194L | UCEC | 1 |
p.P403L | SARC | 1 |
p.P595A | ESCA | 1 |
p.A47V | COAD | 1 |
p.T69A | CESC | 1 |
p.I537T | DLBC | 1 |
p.P295T | LIHC | 1 |
p.P473L | COAD | 1 |
p.A970V | UCEC | 1 |
p.R25G | DLBC | 1 |
p.P763H | UCEC | 1 |
p.S506N | UCEC | 1 |
p.V302E | ESCA | 1 |
p.S273R | LIHC | 1 |
p.P403T | LUAD | 1 |
p.P91S | UCEC | 1 |
p.P968L | UCEC | 1 |
p.S798Y | THYM | 1 |
p.H949Y | COAD | 1 |
p.P337T | BRCA | 1 |
p.M592I | BRCA | 1 |
p.R46C | UCEC | 1 |
p.K287Q | UCEC | 1 |
p.E838K | OV | 1 |
p.Q358X | THYM | 1 |
p.K1020N | UCEC | 1 |
p.S327R | TGCT | 1 |
p.T568I | COAD | 1 |
p.S314Y | UCEC | 1 |
p.S250N | UCEC | 1 |
p.T779A | LIHC | 1 |
p.N371T | DLBC | 1 |
p.S798Y | COAD | 1 |
p.T350I | BRCA | 1 |
p.Q42K | UCEC | 1 |
p.T896S | LIHC | 1 |
p.S550X | THYM | 1 |
p.S207Y | UCEC | 1 |
p.P476S | ESCA | 1 |
p.P473S | THYM | 1 |
p.S564P | UCEC | 1 |
p.A629G | LUAD | 1 |
p.R1029M | UCEC | 1 |
p.R167G | UCEC | 1 |
p.G847D | UCEC | 1 |
p.G769* | ACC | 1 |
p.G364V | UCEC | 1 |
p.R103W | UCEC | 1 |
p.Q33H | SARC | 1 |
p.A967T | COAD | 1 |
p.P214L | ESCA | 1 |
Top |
TissGeneCNV for POM121L2 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for POM121L2 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for POM121L2 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for POM121L2 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for POM121L2 |
TissGeneDrug for POM121L2 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for POM121L2 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0036341 | Schizophrenia | 2 | GAD,GWASCAT |